Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10038630HBVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TVIS10039843HBVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TVIS10042502HBVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TVIS10049760HBVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TVIS10042503HBVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TVIS10040683HBVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TVIS30083389HIVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TVIS30069128HIVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TVIS30069129HIVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TVIS30069130HIVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TCGA Plot Options
Drug Information
GeneKCNB2
DrugBank IDDB06637
Drug NameDalfampridine
Target IDBE0004722
UniProt IDQ92953
Regulation Typeantagonist
PubMed IDs16472864
CitationsJudge SI, Bever CT Jr: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006 Jul;111(1):224-59. Epub 2006 Feb 9.
GroupsApproved
Direct ClassificationAminopyridines and derivatives
SMILESNC1=CC=NC=C1
Pathways
PharmGKBPA166123389
ChEMBLCHEMBL284348